Erythroid progenitor cell kinetics in chronic haemodialysis patients responding to treatment with recombinant human erythropoietin.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3207631)

Published in Br J Haematol on November 01, 1988

Authors

C D Reid1, J Fidler, D O Oliver, P M Cotes, M J Pippard, C G Winearls

Author Affiliations

1: Section of Haematology, Clinical Research Centre, Northwick Park, Harrow.

Articles by these authors

Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42

Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet (1987) 4.20

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet (1986) 4.04

Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med (1985) 2.46

Comparison of multilocus sequence typing and pulsed-field gel electrophoresis as tools for typing Staphylococcus aureus isolates in a microepidemiological setting. J Clin Microbiol (2002) 2.45

Consultant appraisal. QJM (2001) 2.03

Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. Br Med J (Clin Res Ed) (1983) 1.91

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. Lancet (1974) 1.80

Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet (2000) 1.78

Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers. Addiction (2010) 1.69

High incidence of end-stage renal disease in Indo-Asians in the UK. QJM (1995) 1.68

Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure. Br Med J (1966) 1.67

Iron absorption and loading in beta-thalassaemia intermedia. Lancet (1979) 1.66

The international reference preparation of erythropoietin. Bull World Health Organ (1966) 1.60

Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes. Leukemia (2002) 1.59

Cancer in patients receiving dialysis. Br Med J (1980) 1.52

Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Q J Med (1989) 1.49

Prevention of iron loading in transfusion-dependent thalassaemia. Lancet (1978) 1.47

Rapidly progressive glomerulonephritis: what should be first-line therapy? Nephron (1994) 1.42

Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet (1991) 1.42

Heart disease in pregnancy some controversies. J R Coll Physicians Lond (1981) 1.40

In vivo studies on the relationship between intestinal iron (Fe3+) absorption, hypoxia and erythropoiesis in the mouse. Br J Haematol (1988) 1.39

Late renal failure due to prostatic outflow obstruction: a preventable disease. BMJ (1989) 1.38

Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration. Clin Nephrol (1984) 1.36

Plasma ferritin determination as a diagnostic tool. West J Med (1986) 1.34

Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis. Br Med J (Clin Res Ed) (1983) 1.33

Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. Q J Med (1979) 1.28

Late referral for maintenance dialysis. Br Med J (Clin Res Ed) (1984) 1.25

Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet (1997) 1.21

Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods (1987) 1.21

Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis. J Clin Pathol (1987) 1.21

Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol (1982) 1.19

Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration. Br Med J (Clin Res Ed) (1984) 1.14

Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med (1984) 1.13

Graft adaptation: studies on possible mechanisms in long-term surviving rat renal allografts. Transplantation (1980) 1.10

Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction. Clin Exp Immunol (1990) 1.09

Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Res (1987) 1.07

Iron overload in mild sideroblastic anaemias. Lancet (1983) 1.06

Ferrioxamine excretion in iron-loaded man. Blood (1982) 1.06

The effect of erythroid hyperplasia on iron balance. Blood (1988) 1.06

Gastric motor disturbances in patients with idiopathic rapid gastric emptying. Neurogastroenterol Motil (2011) 1.05

Microcytosis, iron deficiency, and thalassaemia in preschool children. Arch Dis Child (1990) 1.05

Development of the immune response in the foetal and newborn rhesus monkey. I. Response to bovine serum albumin. Immunology (1966) 1.05

Simple method for early detection of peritonitis in patients on continuous ambulatory peritoneal dialysis. Lancet (1980) 1.04

Collaborative study of estimates by radioimmunoassay of insulin concentrations in plasma samples examined in groups of five or six laboratories. J Endocrinol (1969) 1.03

Renal complications of jejuno-ileal bypass for obesity. QJM (2001) 1.02

Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstet Gynaecol (1983) 1.01

Vein allografts for arterial replacement in rats: an immunological and histological study. Transplantation (1979) 1.01

Treatment of aggressive idiopathic membranous glomerulonephritis. Q J Med (1994) 0.99

Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol (1985) (1985) 0.99

Acute interstitial nephritis and erythroderma associated with diflunisal. Br Med J (1980) 0.99

Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown. Br Med J (Clin Res Ed) (1981) 0.98

Integration of e-learning resources into a medical school curriculum. Med Teach (2011) 0.98

Renal impairment following biliary tract surgery. Br J Surg (1987) 0.97

Baroreflex sensitivity in patients on long-term haemodialysis. Clin Sci (1972) 0.97

Outcome following staphylococcal peritonitis. Perit Dial Int (2000) 0.96

Cardiovascular abnormalities in osteogenesis imperfecta. Am Heart J (1983) 0.96

Embolism from mural thrombus in the thoracic aorta. Br Med J (1967) 0.96

Oral versus intravenous high-dose steroid treatment of renal allograft rejection. The big shot or not? Lancet (1978) 0.96

Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil. Br Med J (1973) 0.96

Relation of "lymphoid" phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of Ph1 positive leukemia. Cancer (1979) 0.95

Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA). Scand J Haematol (1986) 0.94

Subcutaneous erythropoietin and peritoneal dialysis. Lancet (1989) 0.93

Retinopathy due to progressive systemic sclerosis. J Pathol Bacteriol (1968) 0.93

Passive enhancement and hyperacute rejection of renal allografts in the rat. Transplantation (1980) 0.92

The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial. Br J Obstet Gynaecol (1983) 0.92

Dietary treatment of hyperlipidemia in chronic hemodialysis patients. Am J Clin Nutr (1978) 0.92

Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia. Clin Sci (Lond) (1985) 0.92

Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. Lancet (2003) 0.92

Proliferative glomerulonephritis associated with mantle cell lymphoma--natural history and effect of treatment in 2 cases. Clin Nephrol (2004) 0.92

Renal transplantation and a positive serological cross-match. Lancet (1977) 0.91

Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int (1996) 0.91

Monoclonal antibodies to restricted and cross-reactive idiotopes on monoclonal rheumatoid factors and their recognition of idiotope-positive cells. Eur J Immunol (1987) 0.90

Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Haematologica (2001) 0.90

Hepatocyte iron kinetics in the rat explored with an iron chelator. Br J Haematol (1982) 0.90

Treatment of hyperlipidaemia in patients on chronic haemodialysis. Br Med J (1978) 0.90

Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin. N Engl J Med (1977) 0.90

Surgical correction of burn scar contractures of the foot in children. Burns Incl Therm Inj (1988) 0.90

Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Observations on the associated anemia. Gastroenterology (1984) 0.89

Desferrioxamine-induced iron excretion in humans. Baillieres Clin Haematol (1989) 0.89

Total parathyroidectomy alone or with autograft for renal hyperparathyroidism? Q J Med (1991) 0.88

Changes in serum immunoreactive erythropoietin during the menstrual cycle and normal pregnancy. Br J Obstet Gynaecol (1983) 0.88

Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients. Q J Med (1992) 0.88

The second international reference preparation of erythropoietin, human, urinary, for bioassay. Bull World Health Organ (1972) 0.87

Presentation and survival of patients with severe renal failure and myeloma. QJM (1997) 0.87

Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis. Kidney Int (1988) 0.87

Who gets renal bone disease before beginning dialysis? Br Med J (Clin Res Ed) (1985) 0.86

Mechanism of immune complex-mediated damage: induction of interleukin 1 by immune complexes and synergy with interferon-gamma and tumor necrosis factor-alpha. Eur J Immunol (1989) 0.86

Prospective trial of high-dose versus low-dose prednisolone in renal transplant patients. Transplant Proc (1980) 0.86

Microcytic anaemia in juvenile chronic arthritis. Scand J Rheumatol (1987) 0.86

Pneumocystis carinii pneumonia in renal transplant recipients--clinical and radiographic features, diagnosis and complications of treatment. Q J Med (1985) 0.86